KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $3.25 $5.20 Friday, 26th Apr 2024 AVXL stock ended at $3.44. This is 1.47% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.07% from a day low at $3.38 to a day high of $3.48.
90 days $3.25 $6.82
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Feb 16, 2022 $12.53 $12.82 $12.31 $12.66 625 300
Feb 15, 2022 $12.43 $12.82 $12.34 $12.72 798 300
Feb 14, 2022 $12.45 $12.68 $12.06 $12.12 929 100
Feb 11, 2022 $12.68 $13.22 $12.27 $12.50 963 200
Feb 10, 2022 $11.61 $13.28 $11.41 $12.64 2 117 700
Feb 09, 2022 $11.24 $11.85 $11.02 $11.74 1 362 200
Feb 08, 2022 $10.90 $11.18 $10.58 $11.10 955 000
Feb 07, 2022 $10.52 $11.13 $10.52 $11.00 1 200 700
Feb 04, 2022 $10.18 $10.61 $9.93 $10.43 1 756 300
Feb 03, 2022 $10.44 $10.50 $10.07 $10.23 1 972 000
Feb 02, 2022 $11.69 $11.69 $10.50 $10.55 3 231 700
Feb 01, 2022 $12.20 $12.20 $10.06 $11.04 7 574 100
Jan 31, 2022 $12.13 $13.08 $12.03 $13.08 944 300
Jan 28, 2022 $11.55 $12.17 $11.34 $12.17 796 100
Jan 27, 2022 $12.51 $12.74 $11.50 $11.56 821 300
Jan 26, 2022 $13.23 $13.42 $12.20 $12.29 1 162 800
Jan 25, 2022 $12.40 $13.13 $12.05 $12.94 1 131 000
Jan 24, 2022 $12.02 $12.69 $11.10 $12.60 2 238 100
Jan 21, 2022 $12.50 $13.01 $12.29 $12.38 1 197 300
Jan 20, 2022 $13.87 $13.99 $12.60 $12.65 951 300
Jan 19, 2022 $13.50 $14.23 $13.49 $13.58 1 298 100
Jan 18, 2022 $14.08 $14.23 $13.17 $13.22 1 087 800
Jan 14, 2022 $13.63 $14.46 $13.43 $14.39 1 146 200
Jan 13, 2022 $14.66 $14.86 $13.54 $13.72 1 642 300
Jan 12, 2022 $15.43 $15.48 $14.65 $14.69 772 200
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT